The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Dementia with Lewy bodies risk down with α-1 adrenergic receptor antagonists
Jun 19, 2024
The risk for developing dementia with Lewy bodies was lower for men newly started on Tz/Dz/Az compared with those taking tamsulosin or 5ARI.
Benefit of thick liquids in Alzheimer’s disease and dysphagia unclear
May 06, 2024
Patients receiving thick versus thin liquids were less likely to be intubated and more likely to have respiratory complications.
ACC: Gamification plus financial incentives boost physical activity
Apr 11, 2024
Greatest effect seen during both the 12-month intervention and at six-month follow-up among patients at high risk for cardiovascular events
Endocrine, vascular processes contribute to cognitive decline in women
Apr 03, 2024
Earlier menopause and higher vascular risk were synergistically associated with lower cognitive scores at follow-up.